Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT06508190)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06508190 Sponsor: Ahram Canadian University Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06508190 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

People with a body mass index (BMI) under 35 kg/m² (a measure of body weight relative to height)
People who have been diagnosed with obstructive sleep apnea (a sleep condition where breathing repeatedly stops and starts during sleep) and also have a fatty liver

Who may not be able to join:

People who have had a liver transplant
People whose fatty liver is caused by alcohol use
People who are currently taking antipsychotic medications
People who have had bariatric (weight loss) surgery
People with heart or kidney problems
People who have liver cancer
People who are pregnant
People with orthopedic problems (conditions affecting bones, joints, or muscles)
People with systemic diseases (conditions that affect the whole body)
People with breathing or lung problems
People with neurological conditions (conditions affecting the brain or nervous system)

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: El-Hadidy Hagar, Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt

Phone: 00201007453552

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06508190

Sponsor: Ahram Canadian University

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 00201007453552

More information: https://clinicaltrials.gov/study/NCT06508190

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

People with a body mass index (BMI) under 35 kg/m² (a measure of body weight relative to height)
People who have been diagnosed with obstructive sleep apnea (a sleep condition where breathing repeatedly stops and starts during sleep) and also have a fatty liver

Who may not be able to join:

People who have had a liver transplant
People whose fatty liver is caused by alcohol use
People who are currently taking antipsychotic medications
People who have had bariatric (weight loss) surgery
People with heart or kidney problems
People who have liver cancer
People who are pregnant
People with orthopedic problems (conditions affecting bones, joints, or muscles)
People with systemic diseases (conditions that affect the whole body)
People with breathing or lung problems
People with neurological conditions (conditions affecting the brain or nervous system)

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ahram Canadian University

Registry

ClinicalTrials.gov

Start date

12 July 2024

Est. completion

1 December 2024

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Alanine tranaminase

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov